GlobalData on MSN
Santhera grants Agamree rights to Nxera for DMD
Santhera Pharmaceuticals has entered an exclusive licensing agreement with Nxera Pharma for Agamree (Vamorolone) to treat ...
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...
Sarepta Therapeutics saw its stock skid 11% after the company announced preliminary unaudited 2025 sales results that missed analyst forecasts for its marketed Elevidys® (delandistrogene ...
DMD Systems Recovery, LLC (DMD), a Reuse First® IT Asset Disposition (ITAD) provider and Certified B Corporation, has earned ...
TG Orthodontics by Dr. Tara Gostovich Named “Top Orthodontist in Marlboro for 2025” Marlboro Township, United States - ...
Commercial launch in Switzerland anticipated in H2 2026Pratteln, Switzerland, January 15, 2026 – Santhera Pharmaceuticals (SIX: SANN) announces ...
Dr. Richard M. Sigismondi, a Long Island native and highly trained dentist with more than four decades of experience, has launched a redesigned website for his West Sayville dental practice. The new ...
NY Top Dentists has reviewed and approved Joseph Salim, DMD, FICD of Sutton Place Dental Associates for 2025 based on ...
Vamorolone is approved and marketed as AGAMREE® for the treatment of Duchenne Muscular Dystrophy (DMD) in the US, European Union, UK and ChinaNew ...
Endoxifen program into rare pediatric neuromuscular disease along with previously received Rare Pediatric Disease Designation ...
Maschinenfabrik Reinhausen has made a sale of 100% of the equity share capital in Sukrut Electric Company Pvt. Ltd. to Quality Power Electrical Equipments Ltd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results